Author: Jade Passey
I am the Senior Press Officer for science and health at The Charity - aiming to spread the word about research into brain tumours!
-
Ulixertinib may change childhood brain tumour treatment
New research suggests that ulixertinib may offer one of the first targeted therapies for the most common form of brain tumour in children.
-
Trial finds DCVax-L may prolong the lives of those living with a glioblastoma
A major phase III clinical trial has found that novel treatment DCVax®-L may prolong the lives of people diagnosed with a new or recurrent glioblastoma.
-
World-leading expert appointed as The Brain Tumour Charity neuro-oncology chair at University of Manchester
We are delighted to announce the appointment of the first-ever The Brain Tumour Charity Chair of Translational Neuro-Oncology at The University of Manchester’s Cancer Research Centre (MCRC).